-
FDA approves first therapy for rare joint tumor
drugs
August 05, 2019
The U.S. Food and Drug Administration granted approval to Turalio (pexidartinib) capsules for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT)...
-
FDA Approves Turalio (pexidartinib) for the Treatment of Symptomatic Tenosynovial Giant Cell Tumor (TGCT) in Adults
drugs
August 05, 2019
The U.S. Food and Drug Administration granted approval to Turalio (pexidartinib) capsules for the treatment of adult patients with...
-
Calculated Tumor Area Has Prognostic Value for Melanoma
drugs
July 02, 2019
Calculated Tumor Area Has Prognostic Value for Melanoma.
-
Childhood Brain Tumor Survivors Face More Struggles
drugs
June 26, 2019
Childhood Brain Tumor Survivors Face More Struggles.
-
Cristal Therapeutics to Present Data at the American Society of Clinical Oncology (ASCO) 2019 Annual Meeting on Lead Clinical Candidate CPC634 in Patients With Solid Tumors
b3cnewswire
May 20, 2019
Florence Atrafi, MD, a clinical investigator on the phase 1 NAPOLY study, has received a prestigious ASCO Merit Award in recognition of her abstract that highlights important research findings.
-
Comprehensive tumor profiling promises new therapeutic options for patients with advanced cancer
worldpharmanews
May 05, 2019
Comprehensive tumor profiling promises new therapeutic options for patients with advanced cancer.
-
BioAtla & BeiGene Enter Development Pact
contractpharma
April 15, 2019
Agreement also covers the manufacturing and commercialization of BioAtla’s investigational CAB CTLA-4 antibody (BA3071).
-
HPV Therapy INO-3106 Demonstrates Clinical Efficacy against Rare Respiratory Tract Tumors
americanpharmaceuticalreview
April 11, 2019
HPV Therapy INO-3106 Demonstrates Clinical Efficacy against Rare Respiratory Tract Tumors.
-
CytomX slumps as BMS bails on 3 partnered projects
fiercebiotech
February 28, 2019
Amid an R&D update from CytomX is the news that Bristol-Myers Squibb has abandoned three programs, putting pressure on the biotech’s share price....
-
Using water and gold, Australian researchers discover ‘universal cancer biomarker’
fiercebiotech
January 02, 2019
Australian researchers at the University of Queensland have discovered a unique DNA structure that appears to be shared by many cancers and could be used to .....